Advanced Micro Devices (NASDAQ: AMD) saw its stock climb over 5% in after-hours trading on Tuesday after reporting better-than-expected Q1 earnings and upbeat guidance for Q2, driven by surging AI-related data center demand.
The chipmaker posted earnings per share of $0.96 on revenue of $7.44 billion, surpassing Wall Street expectations of $0.95 EPS on $7.11 billion in revenue, according to Investing.com. Gross margin also expanded, rising to 50% in Q1—up three percentage points from a year earlier.
AMD’s data center segment was the standout performer, with revenue jumping 57% year-over-year to $3.7 billion. This growth was fueled by strong sales of its CPUs and GPUs, both of which are increasingly used in AI workloads and server infrastructure. The company’s AI-driven momentum appears to be mitigating the effects of U.S. restrictions on chip sales to China.
For the second quarter, AMD forecasts revenue of approximately $7.4 billion, plus or minus $300 million, again beating analyst expectations, which were pegged at $7.24 billion. The company’s optimistic guidance underscores the growing role of AI technologies in driving semiconductor industry growth, with AMD emerging as a key beneficiary.
Investors and analysts alike are viewing AMD’s continued strength in the AI and data center markets as a bullish sign amid global supply constraints and geopolitical headwinds. As AI infrastructure spending accelerates, AMD is positioning itself as a top competitor in the high-performance computing space, challenging rivals in both CPU and GPU markets.
With solid Q1 results and confidence in future growth, AMD remains a strong contender in the ongoing AI-fueled chip race.


Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 



